2026 Q3 Portfolio Activity
In 2026 Q3, Integral Health Asset Management, LLC maintained a portfolio of 132 distinct positions. The most significant new addition was AMGEN INC, now representing 1.92% of the total fund value. They heavily accumulated shares in REVOLUTION MEDICINES INC, increasing the position by 233.3%. The fund also reduced its exposure to CVS HEALTH CORP by 54.5%.
Position History
hover any row below to update
Loading…
Total Positions
132
Quarter
2026 Q3
Top Holding
RVMD (7.9%)
Top 10 Concentration
43.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 132
Integral Health Asset Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 7.91% | 11.10% |
#1
Prev: #1
|
5.2 |
—
|
-500,000 | -33.3% |
P
S
|
1,000,000 | $130,340,100 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 7.83% | 6.74% |
#2
Prev: #2
|
5.6 |
—
|
no change | no change |
P
S
|
1,600,000 | $128,978,200 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 5.92% | 3.21% |
#3
2
Prev: #5
|
5.9 |
—
|
400,000 | 20.0% |
P
S
|
2,400,000 | $97,440,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 4.40% | 5.38% |
#4
1
Prev: #3
|
3.3 |
—
|
no change | no change |
P
S
|
1,600,000 | $72,501,000 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 3.97% | 1.78% |
#5
9
Prev: #14
|
4.6 |
—
|
100,000 | 28.6% |
P
S
|
450,000 | $65,389,500 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 3.68% | 1.63% |
#6
11
Prev: #17
|
4.5 |
—
|
505,000 | 67.3% |
P
S
|
1,255,000 | $60,641,600 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 2.83% | 0.76% |
#7
34
Prev: #41
|
4.1 |
—
|
450,000 | 150.0% |
P
S
|
750,000 | $46,590,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 2.80% | 2.90% |
#8
1
Prev: #7
|
1.6 |
—
|
-50,000 | -16.7% |
P
S
|
250,000 | $46,097,500 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.96% | 2.97% |
#9
3
Prev: #6
|
1.3 |
—
|
-250,000 | -14.3% |
P
S
|
1,500,000 | $32,290,000 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMGN
AMGEN INC
|
Healthcare | 1.92% | — |
#10
Prev: #—
|
4.3 |
—
|
75,000 | — |
NEW
|
75,000 | $31,613,250 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LFST
LIFESTANCE HEAL...
|
Healthcare | 1.90% | 1.27% |
#11
11
Prev: #22
|
1.3 |
—
|
-400,000 | -13.3% |
P
S
|
2,600,000 | $31,278,000 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 1.84% | 0.99% |
#12
18
Prev: #30
|
1.7 |
—
|
no change | no change |
P
S
|
40,000 | $30,330,800 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 1.40% | 1.22% |
#13
12
Prev: #25
|
0.6 |
—
|
-75,000 | -45.5% |
P
S
|
90,000 | $23,000,400 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 1.37% | 0.85% |
#14
18
Prev: #32
|
1.5 |
—
|
no change | no change |
P
S
|
100,000 | $22,588,000 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.36% | 1.23% |
#15
9
Prev: #24
|
1.5 |
—
|
no change | no change |
P
S
|
1,000,000 | $22,455,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 1.35% | 2.81% |
#16
8
Prev: #8
|
0.5 |
—
|
-200,000 | -66.7% |
P
S
|
100,000 | $22,250,000 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 1.30% | 4.49% |
#17
13
Prev: #4
|
0.5 |
—
|
-600,000 | -54.5% |
P
S
|
500,000 | $21,422,500 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 1.29% | 1.00% |
#18
11
Prev: #29
|
1.5 |
—
|
no change | no change |
P
S
|
150,000 | $21,276,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 1.27% | 0.78% |
#19
19
Prev: #38
|
1.5 |
—
|
no change | no change |
P
S
|
40,000 | $20,912,400 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.23% | 0.81% |
#20
16
Prev: #36
|
1.0 |
—
|
-200,000 | -10.5% |
P
S
|
1,700,000 | $20,205,000 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.20% | 0.81% |
#21
16
Prev: #37
|
2.5 |
—
|
25,000 | 9.1% |
P
S
|
300,000 | $19,740,000 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INCY
INCYTE CORP
|
Healthcare | 1.18% | — |
#22
Prev: #—
|
4.0 |
—
|
160,000 | — |
NEW
|
160,000 | $19,416,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.16% | 1.02% |
#23
5
Prev: #28
|
1.0 |
—
|
-50,000 | -9.1% |
P
S
|
500,000 | $19,030,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.12% | 1.52% |
#24
5
Prev: #19
|
0.4 |
—
|
-225,000 | -40.9% |
P
S
|
325,000 | $18,443,750 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 1.11% | — |
#25
Prev: #—
|
3.9 |
—
|
50,000 | — |
NEW
|
50,000 | $18,297,000 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 1.11% | 2.80% |
#26
17
Prev: #9
|
1.4 |
—
|
no change | no change |
P
S
|
2,000,000 | $18,285,000 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.10% | 0.19% |
#27
48
Prev: #75
|
3.4 |
—
|
320,000 | 213.3% |
P
S
|
470,000 | $18,038,600 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 1.09% | — |
#28
Prev: #—
|
3.9 |
—
|
100,000 | — |
NEW
|
100,000 | $17,900,000 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.06% | 1.52% |
#29
11
Prev: #18
|
0.4 |
—
|
-500,000 | -55.6% |
P
S
|
400,000 | $17,460,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.05% | 2.23% |
#30
19
Prev: #11
|
0.4 |
—
|
-425,000 | -68.0% |
P
S
|
200,000 | $17,264,000 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ERAS
ERASCA INC
|
Healthcare | 1.01% | 0.72% |
#31
11
Prev: #42
|
2.4 |
—
|
130,000 | 13.0% |
P
S
|
1,130,000 | $16,565,800 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.92% | 0.21% |
#32
42
Prev: #74
|
3.4 |
—
|
275,000 | 275.0% |
P
S
|
375,000 | $15,195,000 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 0.92% | 0.62% |
#33
13
Prev: #46
|
0.9 |
—
|
-25,000 | -12.5% |
P
S
|
175,000 | $15,100,750 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 0.90% | 0.83% |
#34
1
Prev: #35
|
0.4 |
—
|
-60,000 | -40.0% |
P
S
|
90,000 | $14,777,100 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EHC
ENCOMPASS HEALT...
|
Healthcare | 0.89% | — |
#35
Prev: #—
|
3.9 |
—
|
120,000 | — |
NEW
|
120,000 | $14,578,800 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVS
NOVARTIS AG
|
Healthcare | 0.87% | 1.24% |
#36
13
Prev: #23
|
0.3 |
—
|
-100,000 | -50.0% |
P
S
|
100,000 | $14,257,000 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABSI
ABSCI CORPORATI...
|
Healthcare | 0.85% | 0.37% |
#37
27
Prev: #64
|
3.3 |
—
|
500,000 | 62.5% |
P
S
|
1,300,000 | $14,001,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DGX
QUEST DIAGNOSTI...
|
Healthcare | 0.78% | 1.67% |
#38
23
Prev: #15
|
0.3 |
—
|
-145,000 | -72.5% |
P
S
|
55,000 | $12,818,850 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.77% | 0.52% |
#39
14
Prev: #53
|
1.3 |
—
|
no change | no change |
P
S
|
500,000 | $12,765,000 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.76% | 0.53% |
#40
11
Prev: #51
|
1.3 |
—
|
no change | no change |
P
S
|
25,000 | $12,599,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 0.76% | — |
#41
Prev: #—
|
3.8 |
—
|
200,000 | — |
NEW
|
200,000 | $12,480,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EWTX
CALL
EDGEWISE THERAP...
|
CALL Option | 0.74% | — |
#42
Prev: #—
|
3.8 |
—
|
300,000 | — |
NEW
|
300,000 | $12,180,000 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.73% | 1.64% |
#43
27
Prev: #16
|
0.3 |
—
|
-400,000 | -44.4% |
P
S
|
500,000 | $12,080,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.72% | 2.41% |
#44
34
Prev: #10
|
0.3 |
—
|
-300,000 | -54.5% |
P
S
|
250,000 | $11,901,875 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TEVJF
TEVA PHARMACEUT...
|
Healthcare | 0.72% | — |
#45
Prev: #—
|
3.8 |
—
|
300,000 | — |
NEW
|
300,000 | $11,880,000 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.71% | 0.84% |
#46
13
Prev: #33
|
0.3 |
—
|
-175,000 | -46.7% |
P
S
|
200,000 | $11,776,000 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.71% | 0.53% |
#47
5
Prev: #52
|
1.3 |
—
|
no change | no change |
P
S
|
40,000 | $11,649,200 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
LIVANOVA PLC
|
|
Bond/Debt | 0.70% | — |
#48
Prev: #—
|
3.8 |
—
|
150,000 | — |
NEW
|
150,000 | $11,475,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
WAT
WATERS CORP
|
Healthcare | 0.67% | 0.59% |
#49
2
Prev: #47
|
0.3 |
—
|
-15,000 | -37.5% |
P
S
|
25,000 | $10,984,750 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 0.63% | — |
#50
Prev: #—
|
3.8 |
—
|
325,000 | — |
NEW
|
325,000 | $10,458,500 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 132 holdings